American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 830-839, November 2009

Prognostic Value of Kidney Function in Patients With ST-Elevation and Non–ST-Elevation Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention

  • Melchior Seyfarth, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
    • Corresponding Author InformationAddress correspondence to Melchior Seyfarth, MD, Deutsches Herzzentrum München, Lazarettstr 36, 80636 Munich, Germany
  • ,
  • Adnan Kastrati, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
  • ,
  • Johannes F.E. Mann, MD

      Affiliations

    • Department of Nephrology and Hypertension, Städtisches Klinikum Schwabing, Germany
  • ,
  • Gjin Ndrepepa, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
  • ,
  • Robert A. Byrne, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
  • ,
  • Stefanie Schulz, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
  • ,
  • Julinda Mehilli, MD

      Affiliations

    • Deutsches Herzzentrum München, Germany
  • ,
  • Albert Schömig, MD

      Affiliations

    • 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Germany

Received 22 December 2008; accepted 3 April 2009. published online 10 July 2009.

Background

Patients with decreased kidney function and acute ST-elevation myocardial infarction (STEMI) and non-STEMI are less likely to receive reperfusion therapy and aggressive medical treatment. This undertreatment may contribute to the poor outcome of these patients. The prognostic value of kidney function in patients with STEMI and NSTEMI treated predominantly with percutaneous coronary intervention (PCI) and aggressive medical treatment is less known.

Study Design

Prospective cohort study.

Setting & Participants

2 academic centers in Germany; 4,701 consecutive patients with acute myocardial infarction (AMI) from 1998 to 2006.

Predictor

Estimated creatinine clearance (eCCr) at admission.

Outcomes & Measurements

The primary end point was all-cause mortality during the first year after PCI for AMI (STEMI and NSTEMI) with a prespecified landmark at 30 days (landmark analysis). Secondary end points were nonfatal myocardial infarction, stroke, and major bleeding.

Results

Patients were divided into quartiles according to eCCr less than 56, 56 to 76, 77 to 100, and greater than 100 mL/min. Patients had an increased risk of death with decreased eCCr both within 30 days (7.7%, 3.1%, 1.4%, and 0.7% for the 4 quartiles; P < 0.001) and after 30 days (12.1%, 4.8%, 1.9%, and 1.2%; P < 0.001). The association of eCCr with mortality was similar in patients younger and older than 70 years. Major bleeding within 30 days and incidence of stroke also were more frequent with reduced eCCr. However, recurrent myocardial infarction was not associated with eCCr. After adjustment for additional baseline characteristics, kidney function based on eCCr at admission remained a strong independent predictor of mortality at 1 year after AMI (hazard ratio, 1.21 per 10-mL/min decrease; 95% confidence interval, 1.13 to 1.30).

Limitations

Single assessment of eCCr.

Conclusions

In patients with AMI treated with primary PCI for STEMI and early PCI for NSTEMI, eCCr at admission remains a powerful independent predictor of short- and long-term mortality.

Index Words: Kidney function, estimated creatinine clearance, acute myocardial infarction, mortality, landmark analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi: 10.1053/j.ajkd.2009.04.031 on July 10, 2009.

PII: S0272-6386(09)00766-5

doi:10.1053/j.ajkd.2009.04.031

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 830-839, November 2009